Cytoflavin

N/A

Report date: 2022/11/05 14:07:52
NME

Base Information

Drug NameCytoflavin
Drug Alias NameCitoflavin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid peroxidation inhibitors
TargetsNot applicable
Therapy Area/IndicationsHead Injuries, ClosedDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationKazakhstan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPolysan Scientific & Technological Pharmaceutical Company
China Registration ClassN/A

Develop Information

Active CompaniesPolysan Scientific & Technological Pharmaceutical Company
Inactive CompaniesN/A
Active IndicationsHead Injuries, ClosedDiabetic Neuropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A